{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:52:28Z","timestamp":1793404348839,"version":"4.5.0"},"reference-count":68,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"6","license":[{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2025,6,17]]},"DOI":"10.1167\/iovs.66.6.56","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T09:30:40Z","timestamp":1750152640000},"page":"56","source":"Crossref","is-referenced-by-count":5,"title":["Liposome Encapsulation Enhances Ripasudil Therapeutic Efficacy Against Proliferative Vitreoretinal Diseases: Implications in Advanced Ocular Treatment"],"prefix":"10.1167","volume":"66","author":[{"given":"Rui","family":"Ji","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keijiro","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryotaro","family":"Tsukamoto","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacokinetics, Faculty of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Matsunaga","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacokinetics, Faculty of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Kiyohara","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iori","family":"Wada","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Isobe","sequence":"additional","affiliation":[{"name":"Tokyo New Drug Research Laboratories, Kowa Company, Ltd., Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohito","family":"Tanihara","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacokinetics, Faculty of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacokinetics, Faculty of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouta","family":"Mayanagi","sequence":"additional","affiliation":[{"name":"Department of Drug Discovery Structural Analysis, Faculty of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Oyama","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacokinetics, Faculty of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuma","family":"Terada","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacokinetics, Faculty of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaita","family":"Otsuki","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacokinetics, Faculty of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Hamamura","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacokinetics, Faculty of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"DDS Strategy Firm, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Nakao","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Juntendo University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Kurume University School of Medicine, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram","family":"Kannan","sequence":"additional","affiliation":[{"name":"Doheny Eye Institute, Pasadena, California, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigehiro","family":"Ohdo","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koh-Hei","family":"Sonoda","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/IIO.0000000000000258","article-title":"Proliferative vitreoretinopathy: a review","volume":"59","author":"Idrees","year":"2019","journal-title":"Int Ophthalmol Clin"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1056\/NEJMcp2102061","article-title":"Age-related macular degeneration","volume":"385","author":"Apte","year":"2021","journal-title":"N Engl J Med"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.exer.2015.03.009","article-title":"Molecular mechanisms of subretinal fibrosis in age-related macular degeneration","volume":"142","author":"Ishikawa","year":"2016","journal-title":"Exp Eye Res"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.preteyeres.2015.07.005","article-title":"Proliferative vitreoretinopathy: a new concept of disease pathogenesis and practical consequences","volume":"51","author":"Pastor","year":"2016","journal-title":"Prog Retin Eye Res"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/s41433-019-0699-1","article-title":"Proliferative vitreoretinopathy: revised concepts of pathogenesis and adjunctive treatment","volume":"34","author":"Charteris","year":"2020","journal-title":"Eye (Lond)"},{"key":"bib6","first-page":"1325","article-title":"Proliferative vitreoretinopathy: current and emerging treatments","volume":"6","author":"Sadaka","year":"2012","journal-title":"Clin Ophthalmol"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s10384-020-00777-6","article-title":"Recent trends in vitreoretinal surgery: a nationwide database study in Japan, 2010-2017","volume":"65","author":"Hashimoto","year":"2021","journal-title":"Jpn J Ophthalmol"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.ophtha.2013.10.019","article-title":"Risk of scar in the comparison of age-related macular degeneration treatments trials","volume":"121","author":"Daniel","year":"2014","journal-title":"Ophthalmology"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ajo.2013.02.012","article-title":"Subfoveal fibrosis in eyes with neovascular age-related macular degeneration treated with intravitreal ranibizumab","volume":"156","author":"Bloch","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00441-021-03514-8","article-title":"Subretinal fibrosis in neovascular age-related macular degeneration: current concepts, therapeutic avenues, and future perspectives","volume":"387","author":"Tenbrock","year":"2022","journal-title":"Cell Tissue Res"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1167\/iovs.18-25189","article-title":"Identification and quantification of the angiofibrotic switch in neovascular AMD","volume":"60","author":"Roberts","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10384-022-00969-2","article-title":"Recent trends in anti-vascular endothelial growth factor intravitreal injections: a large claims database study in Japan","volume":"67","author":"Hashimoto","year":"2023","journal-title":"Jpn J Ophthalmol"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1350-9462(98)00024-X","article-title":"Matrix and the retinal pigment epithelium in proliferative retinal disease","volume":"18","author":"Hiscott","year":"1999","journal-title":"Prog Retin Eye Res"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.preteyeres.2017.08.001","article-title":"Myofibroblast transdifferentiation: the dark force in ocular wound healing and fibrosis","volume":"60","author":"Shu","year":"2017","journal-title":"Prog Retin Eye Res"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"16386","DOI":"10.1038\/srep16386","article-title":"Resveratrol inhibits epithelial-mesenchymal transition of retinal pigment epithelium and development of proliferative vitreoretinopathy","volume":"5","author":"Ishikawa","year":"2015","journal-title":"Sci Rep"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.ajpath.2015.11.014","article-title":"alphaB-crystallin regulates subretinal fibrosis by modulation of epithelial-mesenchymal transition","volume":"186","author":"Ishikawa","year":"2016","journal-title":"Am J Pathol"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.ajpath.2020.12.012","article-title":"Adrenomedullin-receptor activity-modifying protein 2 system ameliorates subretinal fibrosis by suppressing epithelial-mesenchymal transition in age-related macular degeneration","volume":"191","author":"Tanaka","year":"2021","journal-title":"Am J Pathol"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00109-015-1289-8","article-title":"Attenuation of EMT in RPE cells and subretinal fibrosis by an RAR-gamma agonist","volume":"93","author":"Kimura","year":"2015","journal-title":"J Mol Med (Berl)"},{"key":"bib19","doi-asserted-by":"crossref","DOI":"10.1136\/bjophthalmol-2017-310378","article-title":"ROCK inhibitors for the treatment of ocular diseases","author":"Nourinia","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1167\/iovs.14-15681","article-title":"The effect of AMA0428, a novel and potent ROCK inhibitor, in a model of neovascular age-related macular degeneration","volume":"56","author":"Hollanders","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2337\/db06-0581","article-title":"Transforming growth factor-beta2 and connective tissue growth factor in proliferative vitreoretinal diseases: possible involvement of hyalocytes and therapeutic potential of Rho kinase inhibitor","volume":"56","author":"Kita","year":"2007","journal-title":"Diabetes"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"17504","DOI":"10.1073\/pnas.0804054105","article-title":"Role of TGF-beta in proliferative vitreoretinal diseases and ROCK as a therapeutic target","volume":"105","author":"Kita","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"bib23","first-page":"4913","article-title":"ROCK inhibitor Ripasudil reverses phenotype from EMT to MET in subretinal fibrosis","volume":"60","author":"Wada","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1089\/jop.2016.0028","article-title":"Ocular penetration and pharmacokinetics of ripasudil following topical administration to rabbits","volume":"32","author":"Isobe","year":"2016","journal-title":"J Ocul Pharmacol Ther"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ejpb.2020.05.005","article-title":"Preclinical challenges for developing long acting intravitreal medicines","volume":"153","author":"Awwad","year":"2020","journal-title":"Eur J Pharm Biopharm"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.ejpb.2015.01.003","article-title":"Intravitreal clearance and volume of distribution of compounds in rabbits: in silico prediction and pharmacokinetic simulations for drug development","volume":"95","author":"del Amo","year":"2015","journal-title":"Eur J Pharm Biopharm"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"e1548","DOI":"10.1002\/wnan.1548","article-title":"Fundamentals, challenges, and nanomedicine-based solutions for ocular diseases","volume":"11","author":"Srinivasarao","year":"2019","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1021\/acs.molpharmaceut.0c00224","article-title":"Nanoparticulate drug delivery to the retina","volume":"18","author":"Li","year":"2021","journal-title":"Mol Pharm"},{"key":"bib29","first-page":"253","article-title":"Intravitreal delivery of oligonucleotides by sterically stabilized liposomes","volume":"43","author":"Bochot","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/j.biomaterials.2006.11.028","article-title":"Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP)","volume":"28","author":"Diebold","year":"2007","journal-title":"Biomaterials"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"7348","DOI":"10.1167\/iovs.12-9955","article-title":"EphA2 targeted doxorubicin stealth liposomes as a therapy system for choroidal neovascularization in rats","volume":"53","author":"Wang","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jconrel.2016.03.012","article-title":"Hyaluronic acid-coated liposomes for targeted delivery of paclitaxel, in-vitro characterization and in-vivo evaluation","volume":"229","author":"Ravar","year":"2016","journal-title":"J Control Release"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0168-3659(99)00047-4","article-title":"Gene delivery using liposome technology","volume":"62","author":"Kikuchi","year":"1999","journal-title":"J Control Release"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/(SICI)1099-081X(199611)17:8<699::AID-BDD983>3.0.CO;2-D","article-title":"The effect of adriamycin against a liver metastatic model by encapsulation in liposomes","volume":"17","author":"Yachi","year":"1996","journal-title":"Biopharm Drug Dispos"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1248\/bpb.b12-01106","article-title":"Development of liposomal anticancer drugs","volume":"36","author":"Hyodo","year":"2013","journal-title":"Biol Pharm Bull"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1016\/j.bbamem.2006.05.028","article-title":"Remote loading of doxorubicin into liposomes driven by a transmembrane phosphate gradient","volume":"1758","author":"Fritze","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jsb.2005.07.007","article-title":"Automated electron microscope tomography using robust prediction of specimen movements","volume":"152","author":"Mastronarde","year":"2005","journal-title":"J Struct Biol"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1006\/jsbi.1996.0013","article-title":"Computer visualization of three-dimensional image data using IMOD","volume":"116","author":"Kremer","year":"1996","journal-title":"J Struct Biol"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/nmeth.4405","article-title":"Convolutional neural networks for automated annotation of cellular cryo-electron tomograms","volume":"14","author":"Chen","year":"2017","journal-title":"Nat Methods"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jsb.2006.05.009","article-title":"EMAN2: an extensible image processing suite for electron microscopy","volume":"157","author":"Tang","year":"2007","journal-title":"J Struct Biol"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2013a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J Comput Chem"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1093\/hmg\/ddac020","article-title":"TNFRSF10A downregulation induces retinal pigment epithelium degeneration during the pathogenesis of age-related macular degeneration and central serous chorioretinopathy","volume":"31","author":"Mori","year":"2022","journal-title":"Hum Mol Genet"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/nprot.2009.33","article-title":"A protocol for the culture and differentiation of highly polarized human retinal pigment epithelial cells","volume":"4","author":"Sonoda","year":"2009","journal-title":"Nat Protoc"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/IAE.0000000000001117","article-title":"Permeability and anti-vascular endothelial growth factor effects of bevacizumab, ranibizumab, and aflibercept in polarized retinal pigment epithelial layer in vitro","volume":"37","author":"Yoshihara","year":"2017","journal-title":"Retina"},{"key":"bib45","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.exer.2013.02.012","article-title":"TNF-a disrupts morphologic and functional barrier properties of polarized retinal pigment epithelium","volume":"110","author":"Shirasawa","year":"2013","journal-title":"Exp Eye Res"},{"key":"bib46","doi-asserted-by":"publisher","first-page":"74","DOI":"10.15283\/ijsc20094","article-title":"Human stem cell-derived retinal pigment epithelial cells as a model for drug screening and pre-clinical assays compared to ARPE-19 cell line","volume":"14","author":"Oliveira","year":"2021","journal-title":"Int J Stem Cells"},{"issue":"Pt 3A","key":"bib47","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/eye.2000.92","article-title":"Synthesis pattern of matrix metalloproteinases (MMPs) and inhibitors (TIMPs) in human explant organ cultures after treatment with latanoprost and dexamethasone","volume":"14","author":"el-Shabrawi","year":"2000","journal-title":"Eye (Lond)"},{"key":"bib48","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1021\/acs.molpharmaceut.5b00787","article-title":"Drug distribution to retinal pigment epithelium: studies on melanin binding, cellular kinetics, and single photon emission computed tomography\/computed tomography imaging","volume":"13","author":"Rimpela","year":"2016","journal-title":"Mol Pharm"},{"key":"bib49","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1159\/000063884","article-title":"Effect of tranilast on proliferation, collagen gel contraction, and transforming growth factor beta secretion of retinal pigment epithelial cells and fibroblasts","volume":"34","author":"Yasukawa","year":"2002","journal-title":"Ophthalmic Res"},{"key":"bib50","doi-asserted-by":"publisher","first-page":"4307","DOI":"10.1167\/iovs.09-4605","article-title":"Gene expression profile of hyperoxic and hypoxic retinas in a mouse model of oxygen-induced retinopathy","volume":"51","author":"Ishikawa","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib51","doi-asserted-by":"publisher","first-page":"e94743","DOI":"10.1371\/journal.pone.0094743","article-title":"Improvement and optimization of standards for a preclinical animal test model of laser induced choroidal neovascularization","volume":"9","author":"Zhu","year":"2014","journal-title":"PLoS One"},{"key":"bib52","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1182\/blood-2009-01-197095","article-title":"alphaB-crystallin regulation of angiogenesis by modulation of VEGF","volume":"115","author":"Kase","year":"2010","journal-title":"Blood"},{"key":"bib53","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nprot.2007.4","article-title":"In vivo models of proliferative vitreoretinopathy","volume":"2","author":"Agrawal","year":"2007","journal-title":"Nat Protoc"},{"key":"bib54","doi-asserted-by":"publisher","first-page":"5016","DOI":"10.1167\/iovs.11-7442","article-title":"Expression of PDGFRa is a determinant of the PVR potential of ARPE19 cells","volume":"52","author":"Lei","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib55","first-page":"1024","article-title":"Intravitreal pharmacokinetics and retinal concentrations of ganciclovir and foscarnet after intravitreal administration in rabbits","volume":"42","author":"Lopez-Cortes","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib56","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.preteyeres.2016.12.001","article-title":"Pharmacokinetic aspects of retinal drug delivery","volume":"57","author":"Del Amo","year":"2017","journal-title":"Prog Retin Eye Res"},{"key":"bib57","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1167\/iovs.07-0667","article-title":"N-(4-hydroxyphenyl) retinamide augments laser-induced choroidal neovascularization in mice","volume":"49","author":"Sreekumar","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib58","doi-asserted-by":"publisher","first-page":"5670","DOI":"10.1167\/iovs.10-6625","article-title":"Increased expression of periostin in vitreous and fibrovascular membranes obtained from patients with proliferative diabetic retinopathy","volume":"52","author":"Yoshida","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib59","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1096\/fj.13-229740","article-title":"Periostin promotes the generation of fibrous membranes in proliferative vitreoretinopathy","volume":"28","author":"Ishikawa","year":"2014","journal-title":"FASEB J"},{"key":"bib60","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1006\/exer.1994.1114","article-title":"Transforming growth factor beta 2 is the predominant isoform in the neural retina, retinal pigment epithelium-choroid and vitreous of the monkey eye","volume":"59","author":"Pfeffer","year":"1994","journal-title":"Exp Eye Res"},{"key":"bib61","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s11095-012-0874-6","article-title":"Effect of PEGylation on biodistribution and gene silencing of siRNA\/lipid nanoparticle complexes","volume":"30","author":"Bao","year":"2013","journal-title":"Pharm Res"},{"key":"bib62","doi-asserted-by":"publisher","first-page":"e0241006","DOI":"10.1371\/journal.pone.0241006","article-title":"The effects of PEGylation on LNP based mRNA delivery to the eye","volume":"15","author":"Ryals","year":"2020","journal-title":"PLoS One"},{"key":"bib63","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.preteyeres.2013.04.001","article-title":"Nanomedicines for back of the eye drug delivery, gene delivery, and imaging","volume":"36","author":"Kompella","year":"2013","journal-title":"Prog Retin Eye Res"},{"key":"bib64","doi-asserted-by":"publisher","first-page":"4279","DOI":"10.1021\/nn3008383","article-title":"Surface charge-switching polymeric nanoparticles for bacterial cell wall-targeted delivery of antibiotics","volume":"6","author":"Radovic-Moreno","year":"2012","journal-title":"ACS Nano"},{"key":"bib65","doi-asserted-by":"publisher","first-page":"6688","DOI":"10.1021\/acs.analchem.5b00847","article-title":"Lysosomal pH decrease in inflammatory cells used to enable activatable imaging of inflammation with a sialic acid conjugated profluorophore","volume":"87","author":"Yu","year":"2015","journal-title":"Anal Chem"},{"key":"bib66","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1016\/j.molcel.2023.06.004","article-title":"Lysosomal LAMP proteins regulate lysosomal pH by direct inhibition of the TMEM175 channel","volume":"83","author":"Zhang","year":"2023","journal-title":"Mol Cell"},{"key":"bib67","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.semnephrol.2013.11.009","article-title":"Regulation of autophagy by TGF-beta: emerging role in kidney fibrosis","volume":"34","author":"Ding","year":"2014","journal-title":"Semin Nephrol"},{"key":"bib68","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41467-019-14262-3","article-title":"TGFbeta2-induced formation of lipid droplets supports acidosis-driven EMT and the metastatic spreading of cancer cells","volume":"11","author":"Corbet","year":"2020","journal-title":"Nat Commun"}],"container-title":["Investigative Ophthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2803143","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:32:08Z","timestamp":1791927128000},"score":1,"resource":{"primary":{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2803143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":68,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6,2]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.66.6.56","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,17]]}}}